Skip to content

Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting

A Placebo-controlled Clinical Trial Investigating the Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting

Status
Enrolling by invitation
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05282706
Enrollment
200
Registered
2022-03-16
Start date
2022-05-16
Completion date
2026-12-31
Last updated
2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suffering, Physical, Nausea

Keywords

Acute Care, Physical Therapy, Occupational Therapy, Aromatherapy

Brief summary

Use of inhaled essential oils to reduce the symptoms of pain or nausea, enabling a patient to have increase participation with PT or OT, thereby minimizing hospitalization-related risks and potentially reducing the length of stay in the hospital.

Detailed description

The study intervention consists of 3 essential oils: lavender, mandarin and peppermint administered on an inhalation patch affixed in the chest region of the participant gown. The inhalation patch consists of hydrogel cast onto polyester film, supported by non-woven polyester fabric, covered with a polyethylene film. The proprietary foil-backed lamination on the patch is used to provide an occlusive barrier that prevents any essential oil from being absorbed through the skin. The placebo will consist of a comparable sized felt patch with adhesive backing with no essential oil applied.

Interventions

OTHERPlacebo

A placebo patch containing no aromatherapy oil

A hydrogel lavender oil infused aromatherapy patch

DRUGMandarin Oil

A hydrogel mandarin oil infused aromatherapy patch

A hydrogel peppermint oil infused aromatherapy patch

Sponsors

University Health
CollaboratorUNKNOWN
The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Subjects will be assigned to an arm based upon the symptoms they are experiencing prior to their therapy session. If a patient reports nausea symptom, they will be assigned to the peppermint fragrance or a placebo. The randomization will be conducted in a 1:2 ratio, one placebo to two experimental. If a patient reports pain symptom, they will be assigned to the lavender or mandarin fragrance or placebo. The randomization will be conducted in a 1:2 ratio, one placebo to two experimental. The experimental group will then be randomized to a 1:1 ratio between lavender and mandarin. For those that refuse the aromatherapy patch will be asked to serve as a control and receive usual care with no patch.

Intervention model description

Three interventional and one control arm

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Inpatients of acute care setting at University Health hospital 2. Provision of a signed and dated informed consent form 3. English or Spanish speaking 4. Male or Female, aged 18 years and older 5. Willing to comply with all study procedures

Exclusion criteria

1. Respiratory disorders, e.g., asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, lung cancer, cystic fibrosis, pneumonia, pleural effusion 2. Cognitive impairment 3. Unable to communicate 4. Admitted to the closed access unit or to psychiatry 5. Allergic to lavender, mandarin or peppermint oil 6. Diseases that cause olfactory disorders such as: COVID-19, benign growths or polyps, congestion from a cold, sinus infection or allergy flare-up 7. Drugs that may cause loss of the ability to smell e.g., intranasal zinc products, decongestant nose sprays and certain oral drugs such as nifedipine and phenothiazines 8. Pregnant women (self-reported) 9. Prisoner

Design outcomes

Primary

MeasureTime frameDescription
Completion of PT/OT session30 minutesThe number of subjects who successfully completed physical or occupational therapy session

Secondary

MeasureTime frameDescription
Change in Pain/Nausea ScaleBaseline to post therapy follow-up (30 minutes)A scale with ranks the pain or nausea from 0 to 10 with a 0 being no pain or nausea and 10 being the worst pain

Other

MeasureTime frameDescription
Increase in participation in PT and OT sessions30 minutesAn exploratory measure to compare whether the use of aromatherapy changes the number of participants in PT or OT.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026